Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Consolidated Net Profit

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹142 Cr₹155 Cr₹93 Cr₹24 Cr₹-2.90 Cr

What is the latest Consolidated Net Profit of INDOCO REMEDIES ?

The latest Consolidated Net Profit ratio of INDOCO REMEDIES is ₹142 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹142 Cr
Mar2023₹155 Cr
Mar2022₹93 Cr
Mar2021₹24 Cr
Mar2020₹-2.90 Cr

How is Consolidated Net Profit of INDOCO REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹142 Cr
-8.11
Mar2023 ₹155 Cr
66.37
Mar2022 ₹93 Cr
285.81
Mar2021 ₹24 Cr
Positive
Mar2020 ₹-2.90 Cr -

Compare Consolidated Net Profit of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,004.8 Cr -1% 16.4% -3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-1%

16.4%

-3.9%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses